Cite
HARVARD Citation
Bachmann, F. et al. (2021). Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. Clinical pharmacology & therapeutics. 109 (6), pp. 1505-1516. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bachmann, F. et al. (2021). Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. Clinical pharmacology & therapeutics. 109 (6), pp. 1505-1516. [Online].